JP2018168171A5 - - Google Patents

Download PDF

Info

Publication number
JP2018168171A5
JP2018168171A5 JP2018117808A JP2018117808A JP2018168171A5 JP 2018168171 A5 JP2018168171 A5 JP 2018168171A5 JP 2018117808 A JP2018117808 A JP 2018117808A JP 2018117808 A JP2018117808 A JP 2018117808A JP 2018168171 A5 JP2018168171 A5 JP 2018168171A5
Authority
JP
Japan
Prior art keywords
compound
following structure
following
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018117808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018168171A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018168171A publication Critical patent/JP2018168171A/ja
Publication of JP2018168171A5 publication Critical patent/JP2018168171A5/ja
Pending legal-status Critical Current

Links

JP2018117808A 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法 Pending JP2018168171A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361801641P 2013-03-15 2013-03-15
US61/801,641 2013-03-15
EP13306056 2013-07-23
EP13306056.6 2013-07-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015562366A Division JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Publications (2)

Publication Number Publication Date
JP2018168171A JP2018168171A (ja) 2018-11-01
JP2018168171A5 true JP2018168171A5 (enExample) 2019-01-17

Family

ID=51538203

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015562366A Active JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法
JP2018117808A Pending JP2018168171A (ja) 2013-03-15 2018-06-21 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2015562366A Active JP6438417B2 (ja) 2013-03-15 2014-03-14 スフィンゴミエリンおよびジヒドロスフィンゴミエリンの合成のための方法

Country Status (16)

Country Link
US (3) US20140316154A1 (enExample)
EP (3) EP3842443B1 (enExample)
JP (2) JP6438417B2 (enExample)
KR (1) KR20150132188A (enExample)
CN (1) CN105051051B (enExample)
AU (2) AU2014229638B2 (enExample)
BR (1) BR112015023558A2 (enExample)
CA (1) CA2900902C (enExample)
DK (1) DK3363805T3 (enExample)
ES (1) ES3017659T3 (enExample)
HK (1) HK1214266A1 (enExample)
MX (1) MX387128B (enExample)
PH (1) PH12015501835A1 (enExample)
SG (2) SG11201506456VA (enExample)
WO (1) WO2014140787A2 (enExample)
ZA (1) ZA201505860B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2396017B1 (en) 2009-02-16 2015-07-01 Cerenis Therapeutics Holding SA Apolipoprotein a-i mimics
ES2646835T3 (es) 2010-10-18 2017-12-18 Cerenis Therapeutics Holding Sa Compuestos, composiciones y procedimientos útiles para la movilización del colesterol
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US20140316154A1 (en) * 2013-03-15 2014-10-23 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
TW201919686A (zh) 2017-08-10 2019-06-01 法商塞勒尼斯醫療控股公司 脫輔基子(apomers)
ES2984285T3 (es) 2017-08-10 2024-10-29 Abionyx Pharma Sa Cargómeros
JPWO2019189133A1 (ja) * 2018-03-27 2021-03-18 日油株式会社 スフィンゴミエリン誘導脂質およびその製造方法
JP7303618B2 (ja) * 2018-10-05 2023-07-05 日本精化株式会社 スフィンゴリン脂質前駆体及びその製造方法、並びに、スフィンゴリン脂質の製造方法
WO2021209808A1 (en) 2020-04-16 2021-10-21 Abionyx Pharma Sa Cer-001 therapy for treating kidney disease
US11752163B2 (en) 2020-04-16 2023-09-12 Abionyx Pharma Sa CER-001 therapy for treating kidney disease
US20240033322A1 (en) 2020-04-16 2024-02-01 Abionyx Pharma Sa Methods for treating acute conditions using lipid binding protein-based complexes
EP4221686A2 (en) 2020-10-01 2023-08-09 Abionyx Pharma SA Compositions comprising lipid binding protein-based complexes for use for treating eye diseases
WO2022219413A1 (en) 2021-04-15 2022-10-20 Abionyx Pharma Sa Use of lipid binding protein-based complexes in organ preservation solutions
AU2023251245A1 (en) 2022-04-06 2024-11-14 Abionyx Pharma Sa Methods for treating leukocytosis, endothelial dysfunction and carditis using lipid binding protein-based complexes
JP2025511845A (ja) 2022-04-06 2025-04-16 アビオニクス ファーマ エスエー 脂質結合タンパク質ベースの複合体を使用した、眼疾患を治療するための方法
JP2025519606A (ja) 2022-06-10 2025-06-26 アビオニクス ファーマ エスエー 脂質結合タンパク質に基づく複合体を使用して急性状態を処置するための方法
IL317448A (en) 2022-06-10 2025-02-01 Abionyx Pharma Sa Methods for treating hyperinflammatory conditions using complexes based on lipid-binding proteins
JP2025521721A (ja) 2022-06-28 2025-07-10 アビオニクス ファーマ エスエー スフィンゴミエリンの合成のための化合物およびプロセス
JP2026504047A (ja) 2023-01-13 2026-02-03 アビオニクス ファーマ エスエー 脂質結合タンパク質分子療法
WO2025093929A1 (en) 2023-10-31 2025-05-08 Abionyx Pharma Sa Lipid binding protein molecule therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146810A3 (de) 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
US5220043A (en) * 1991-03-21 1993-06-15 Ohio University Synthesis of D-erythro-sphingomyelins
US5766627A (en) 1993-11-16 1998-06-16 Depotech Multivescular liposomes with controlled release of encapsulated biologically active substances
DK0729351T3 (da) 1993-11-16 2000-10-16 Skyepharma Inc Vesikler med reguleret afgivelse af aktivstoffer
US6610835B1 (en) * 1998-02-12 2003-08-26 Emory University Sphingolipid derivatives and their methods of use
JP2004002215A (ja) * 2002-05-23 2004-01-08 National Institute Of Advanced Industrial & Technology スフィンゴ脂質誘導体の製造方法
CA2552797A1 (en) 2004-01-15 2005-07-28 Biolab Ltd. Sphingomyelin, intermediates thereof and methods for preparation of same
DE602005018043D1 (de) 2004-05-17 2010-01-14 Tekmira Pharmaceuticals Corp Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
EP1763342B1 (en) 2004-06-29 2008-12-17 Jado Technologies GmbH Sphingolipids against pathological processes in lipid rafts
JP4825947B2 (ja) 2004-08-04 2011-11-30 学校法人関西学院 不飽和アミノジオール類の製造方法
JP2006045113A (ja) 2004-08-04 2006-02-16 Kemikurea:Kk リン酸エステル類
US8206750B2 (en) 2005-03-24 2012-06-26 Cerenis Therapeutics Holding S.A. Charged lipoprotein complexes and their uses
TWI387603B (zh) * 2005-07-20 2013-03-01 Merck Sharp & Dohme Hcv ns3蛋白酶抑制劑
JP2007204384A (ja) 2006-01-31 2007-08-16 Kemikurea:Kk 光学活性リン酸誘導体およびこれを用いた光学活性スフィンゴシン1−リン酸誘導体の製造方法
JP5429734B2 (ja) * 2007-02-09 2014-02-26 国立大学法人岐阜大学 スフィンゴ糖脂質の合成法
ATE526313T1 (de) * 2007-03-09 2011-10-15 Otsuka Chemical Co Ltd Sphingosinverbindung, verfahren zu deren herstellung und sphingomyelinaseinhibitor
CN102223878A (zh) 2008-10-07 2011-10-19 耶路撒冷希伯来大学伊森姆研究发展公司 包含鞘磷脂的脂质体系统
HRP20190138T1 (hr) 2011-02-07 2019-03-22 Cerenis Therapeutics Holding Sa Lipoproteinski kompleksi i njihova proizvodnja i uporaba
FR3000959B1 (fr) * 2013-01-14 2015-08-21 Holis Technologies Nouveaux intermediaires de synthese permettant d'acceder avec de bons rendements a des derives de sphingosines, ceramides et sphingomyelines
US20140316154A1 (en) 2013-03-15 2014-10-23 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins

Similar Documents

Publication Publication Date Title
JP2018168171A5 (enExample)
JP2021020948A5 (enExample)
JP2017008120A5 (enExample)
JP2018024670A5 (enExample)
JP2019089762A5 (enExample)
JP2020515557A5 (enExample)
JP2018150298A5 (enExample)
JP2020040981A5 (enExample)
JP2020007340A5 (enExample)
JP2019194236A5 (enExample)
JP2020534795A5 (enExample)
JP2019068846A5 (enExample)
JP2019124943A5 (enExample)
JP2018521020A5 (enExample)
JP2010019854A5 (enExample)
JP2018030858A5 (enExample)
JP2019164961A5 (enExample)
JP2021503553A5 (enExample)
JP2021502338A5 (enExample)
JP2018116258A5 (enExample)
JP2021163968A5 (enExample)
JP2018186811A5 (enExample)
JP2022027575A5 (enExample)
JP2018162319A5 (enExample)
JP2019210167A5 (enExample)